• 4-Hydroxytamoxifen: Technical Guidance for Cancer Research W

  2026-05-09

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator that addresses the need for DMSO-soluble compounds in breast cancer, prostate cancer, and cardiac myocyte research. It should not be used in protocols requiring aqueous or ethanol solubility, and strict storage and preparation protocols are essential to maintain reagent integrity.

• Lipid Peroxidation (MDA) Assay Kit: Advanced Workflows & App

  2026-05-08

  Unlock new dimensions in oxidative stress research with the Lipid Peroxidation (MDA) Assay Kit. This guide delivers actionable workflow enhancements, troubleshooting strategies, and translational applications—bridging mechanistic discoveries to robust, reproducible results.

• LLY-507: Precision SMYD2 Inhibition for Advanced Cancer Rese

  2026-05-08

  LLY-507 empowers researchers with nanomolar precision to dissect SMYD2-driven pathways in cancer and fibrosis. Its high selectivity and robust cellular activity streamline experimental workflows, making it an indispensable SMYD2 inhibitor for translational studies.

• Injectable GelMA/QCS/Ca2+ Adhesive for Rapid Hemostasis and

  2026-05-07

  This study introduces an injectable, photo-crosslinked GelMA/QCS/Ca2+ adhesive for effective hemostasis and antibacterial protection in non-compressible wounds. The dual-network design leverages natural polymer modification and ionic interactions to outperform commercial fibrin glue in both rapid bleeding control and infection mitigation, with significant implications for emergency wound care.

• Digestive Transformation of Withania somnifera: LC–MS/MS Ins

  2026-05-07

  This study applies advanced LC–MS/MS metabolomics to profile how major bioactives in Withania somnifera (ashwagandha) extracts are transformed during simulated digestion. The findings reveal selective stability and transformation among withanolides, informing the design of in vitro assays and preclinical evaluation of complex botanicals.

• Baicalin: Translational Advances in Visual Cortex Plasticity

  2026-05-06

  Explore how Baicalin modulates the KEAP1-NRF2/HO-1 pathway to restore visual plasticity and sensitize cancer cells. This article reveals new, actionable insights for research assay design and translational neuroscience, setting it apart from prior content.

• Ampicillin Sodium: β-Lactam Antibiotic for High-Fidelity Res

  2026-05-06

  Ampicillin sodium (SKU A2510) from APExBIO delivers reproducible, high-purity β-lactam antibiotic performance for antibacterial activity assays and advanced resistance modeling. This guide translates bench-validated workflows into actionable protocols, ensuring robust results in both routine and translational research.

• Primidone (Mysoline) in Translational Neuro & Gynecology Res

  2026-05-05

  Primidone (Mysoline) advances research in neurodevelopmental and gynecological models with dual inhibition of TRPM3 and RIPK1, while uniquely avoiding aromatase-mediated endocrine disruption. This article delivers actionable workflows, troubleshooting strategies, and data-driven protocol enhancements for maximizing reproducibility and mechanistic clarity.

• Bardoxolone Methyl for Redox Modulation in Cancer Research

  2026-05-05

  Bardoxolone methyl (CDDO methyl ester) enables targeted modulation of the Nrf2 and NF-kB pathways, offering unique leverage for oxidative stress and inflammation studies. This article delivers actionable workflows, advanced applications, and troubleshooting strategies for cancer and kidney disease models, based on the latest redox biology and combinatorial therapy research.

• CHIR-99021 (CT99021): Precision GSK-3 Inhibition for Stem Ce

  2026-05-04

  CHIR-99021 (CT99021) is a benchmark selective GSK-3 inhibitor enabling reproducible control of pluripotency, differentiation, and signaling in stem cell workflows. This article delivers stepwise guidance, experimental troubleshooting, and data-backed protocol enhancements, translating recent reference findings into practical lab strategies.

• Palbociclib (PD0332991): Applied Workflows for Tumor Models

  2026-05-04

  Palbociclib (PD0332991) Isethionate transforms cancer research by enabling precise cell cycle G0/G1 arrest and apoptosis assays in advanced assembloid and organoid models. This guide bridges mechanistic insights with actionable protocols, troubleshooting, and translational applications, leveraging APExBIO’s trusted reagent for maximum data fidelity.

• Stiripentol: LDH Inhibition for Epilepsy and Immunometabolic

  2026-05-03

  Explore how Stiripentol, a novel LDH inhibitor, is redefining translational research by bridging epilepsy models and tumor immunometabolism. This article provides mechanistic insights, experimental best practices, and strategic guidance for researchers leveraging LDH inhibition in metabolic, neurological, and immuno-oncology studies.

• Reliable Pyroptosis Detection with Caspase-4 Colorimetric As

  2026-05-02

  This article addresses laboratory challenges in cell viability and pyroptosis studies, showcasing how the Caspase-4 Colorimetric Assay Kit (SKU K2199) from APExBIO delivers reproducible, quantitative LEVD-dependent caspase-4 activity detection. Drawing on published literature and validated protocols, it offers scenario-driven guidance for robust experimental workflows and informed reagent selection.

• Prochlorperazine: Translating Dopamine Antagonism to Cancer

  2026-05-02

  This thought-leadership piece explores how Prochlorperazine, a dopamine D2 receptor antagonist, is redefining translational research at the interface of antiemetic therapy, melanoma research, and antiviral discovery. Integrating mechanistic insights, protocol best practices, and a critical appraisal of the competitive landscape, the article provides actionable guidance for researchers aiming to harness Prochlorperazine’s multifaceted pharmacology in preclinical and clinical workflows.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-05-01

  This study introduces a glabridin-gold(I) complex (6d) as a dual-action immunomodulatory agent, targeting thioredoxin reductase (TrxR) and MAPK pathways to synergistically increase antitumor immunity in liver cancer. By promoting dendritic cell maturation and mitigating immunosuppressive cell populations, 6d offers a promising strategy to overcome tumor immune evasion.

16206 records 1/1081 page Next 12345 下5页 Last page